Promotion

EvoPure RNA Tissue Isolation Kit

Price range: $425.00 through $1,328.00

RNA tissue isolation made simple. Achieve high-integrity recovery from soft, fibrous, and lipid-rich tissues without organic solvents, hazardous or plastic waste.

Categories: , SKU: R-907T

Available Options:

Description

Product Details

The EvoPure RNA Tissue Isolation Kit leverages Aline’s proprietary magnetic bead technology to provide simplified, high-throughput isolation of total RNA with high integrity. This versatile technology achieves high recovery of total RNA from a wide variety of sources, including soft, fibrous, and lipid-rich tissues. The kit maximizes yields without hazardous waste, organic solvents, or plastic waste and is engineered to perform comparably or superior to Beckman Coulter’s RNAdvance Tissue.

 

Key Features

  • Simple and easy protocol
  • High throughput compatible with all major automation platforms
  • High RNA integrity number
  • Consistent results
  • No hazard or organic solvents
  • No plastic waste generated
  • Cost-effective
  • Excellent alternative to column-based purification
  • All downstream applications for RNA

 

Automation platforms

  • Performance comparable to Biomek, Hamilton, KingFisher, and other major automation platforms on the market
  • Compatible with all major automation platforms

Sizes:

  • 100 preps
  • 400 preps

Storage:

  • EvoPure bind (magnetic beads): 2-8°C
  • Store all buffers at room temperature

Stability:

  • 12 months if stored as specified

 

Disclaimer: For research use only. Not for use in diagnostic procedures.

Protocol

Protocol-EvoPure Tissuel RNA v2.12.pdf

 

Product References

  1. Xu, Jing et al. BioTechniques vol. 75,2 (2023): 47-55. doi:10.2144/btn-2023-0011
    A high-throughput pipeline for DNA/RNA/small RNA purification from tissue samples for sequencing.
    https://doi.org/10.2144/btn-2023-0011
  2. Chahal, M., et al. Cold Spring Harbor molecular case studies4(2), a002626. (2018).
    Personalized oncogenomic analysis of metastatic adenoid cystic carcinoma: using whole-genome sequencing to inform clinical decision-making. https://doi.org/10.1101/mcs.a002626